Related Experiment Video
Updated: Jan 11, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Role of chemokines in depression: Highlights on CX3CL1/CX3CR1 signaling
Yong-Yu Yin1, Yun-Feng Li1,2
1Beijing Institute of Pharmacology and Toxicology, China.
Insights
Chemokine signaling involving CX3CL1 (Fractalkine) and its receptor CX3CR1 is crucial for brain function. This pathway impacts neuroinflammation and synaptic plasticity, offering insights into depression mechanisms and treatments.
Area of Science:
- Neuroscience
- Immunology
- Psychiatry
Background:
- Depression is a widespread mental disorder with unclear underlying mechanisms.
- Chemokine signaling, specifically CX3CL1/CX3CR1, is increasingly implicated in depression's pathophysiology.
- CX3CL1 (Fractalkine) binds to CX3CR1, mediating microglial-neuronal communication in the CNS.
Purpose of the Study:
- To provide a comprehensive review of CX3CL1/CX3CR1 signaling.
- To explore its role in neuroinflammation, synaptic plasticity, and cognition.
- To discuss its significance in depression pathophysiology and treatment.
Main Methods:
- This study is a narrative review.
- It synthesizes existing research on CX3CL1/CX3CR1 signaling.
- Focuses on its involvement in neurological and psychiatric conditions.
Main Results:
- CX3CL1/CX3CR1 signaling is a critical regulator of neuroinflammation and synaptic plasticity.
- This pathway influences neuronal communication and brain function.
- Evidence suggests its involvement in the development and progression of depression.
Conclusions:
- The CX3CL1/CX3CR1 pathway is a key player in the neurobiological underpinnings of depression.
- Understanding this signaling is vital for developing novel antidepressant strategies.
- This review highlights the pathway's significance in neuropsychopharmacology.
Abstract:
Depression is a prevalent and debilitating mental disorder, and the underlying mechanisms of depression remain unclear. Emerging evidence highlights the importance of chemokines, particularly CX3CL1/CX3CR1 signaling, in the pathophysiology of depression. CX3CL1 (Fractalkine, CX3C chemokine ligand 1) is an essential chemokine and exerts its biological effects by binding to its receptor, CX3CR1. This interaction plays a pivotal role in mediating communication between microglia and neurons within the central nervous system. Numerous studies have suggested that CX3CL1/CX3CR1 signaling is a critical regulator of neuroinflammation and synaptic plasticity. Therefore, this narrative review provides a comprehensive overview of the role of CX3CL1/CX3CR1 signaling in neuroinflammation, synaptic plasticity, and cognition. In addition, we discuss the critical role of this signaling pathway in the pathophysiology of depression and antidepressant treatments and highlight its significance in the field of neuropsychopharmacology.
More Related Videos
Related Concept Videos
Depression: Overview
Chemotaxis and Direction of Cell Migration
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
G-protein Coupled Receptors
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Chemical Signaling in the Endocrine System
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...

